Eganelisib (IPI-549): Selectivity & Specificity
Eganelisib (IPI-549) is a potent inhibitor of PIK3CG (7.9–83 nM), ABCB1. Eganelisib (IPI-549) exhibits the greatest inhibitory potency toward PIK3CG (IC50 = 7.9–83 nM).
Jump to
- Eganelisib (IPI-549) Mechanism of Action: PI3Kγ Inhibition in Tumor-Associated Macrophage Research
- Eganelisib (IPI-549) Clinical Trials
- Eganelisib (IPI-549) Working Concentration | Cell Culture | Treatment
- Eganelisib (IPI-549) Solubility in DMSO
- Eganelisib (IPI-549) Stock Solution
- Eganelisib (IPI-549) Storage
- Eganelisib (IPI-549) Stability
- Eganelisib (IPI-549) Combination Database
- Eganelisib (IPI-549) Molecular Weight
- Eganelisib (IPI-549) SMILES
- Eganelisib (IPI-549) CAS Number
- Eganelisib (IPI-549) Chemical Structure (2D and 3D)
- Eganelisib (IPI-549) Sigma (AMBH2D700F13)? Try a better option.
- Eganelisib (IPI-549) MedChemExpress (HY-100716)? Try a better option.
- Eganelisib (IPI-549) Cayman (26416)? Try a better option.
- Eganelisib (IPI-549) APExBIO (C9059)? Try a better option.
- Eganelisib (IPI-549) SDS｜MSDS